Literature DB >> 9570135

IL-6-regulated transcription factors.

S Akira1.   

Abstract

Through the cloning of two transcription factors named NF-IL6 and STAT3/APRF, two types of IL-6 signal transduction pathways from the cell surface to the nucleus have been revealed. NF-IL6 is phosphorylated and activated by a Ras-dependent MAP kinase cascade, while STAT3/APRF is directly tyrosine-phosphorylated by JAK kinases that associate with the cytoplasmic portion of the receptor, and translocates to the nucleus and activates transcription (JAK-STAT pathway). STAT3 is also tyrosine phosphorylated in response to epidermal growth factor (EGF), granulocyte colony-stimulating factor (G-CSF), leptin and other IL-6-type cytokines including ciliary neurotrophic factor (CNTF), oncostatin M and leukemia inhibitory factor (LIF). Mice deficient in the genes for NF-IL6 and STAT3 were generated. NF-IL6 mice were highly susceptible to facultative intracellular bacteria owing to ineffective killing of the pathogens by the macrophages. Futhermore, the tumor cytotoxicity of macrophages from NF-IL6 KO mice was severely impaired. These results demonstrate a crucial role of NF-IL6 in macrophage bactericidal and tumoricidal activities. The target disruption of STAT3 resulted in embryonic lethality prior to gastrulation, demonstrating that STAT3 is essential for the early development of mouse embryos.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9570135     DOI: 10.1016/s1357-2725(97)00063-0

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  59 in total

1.  Cytokine-responsive induction of SAF-1 activity is mediated by a mitogen-activated protein kinase signaling pathway.

Authors:  Alpana Ray; Guang-Yao Yu; Bimal K Ray
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

Review 2.  Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway.

Authors:  E Carla Parker-Athill; Jun Tan
Journal:  Neurosignals       Date:  2010-10-02

3.  Stat-3 is required for pulmonary homeostasis during hyperoxia.

Authors:  Isamu Hokuto; Machiko Ikegami; Mitsuhiro Yoshida; Kiyoshi Takeda; Shizuo Akira; Anne-Karina T Perl; William M Hull; Susan E Wert; Jeffrey A Whitsett
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

4.  Experimental human cytomegalovirus latency in CD14+ monocytes.

Authors:  Danna Hargett; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

5.  Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production.

Authors:  Soonkyu Chung; J Mark Brown; J Nathan Provo; Robin Hopkins; Michael K McIntosh
Journal:  J Biol Chem       Date:  2005-09-09       Impact factor: 5.157

6.  Interleukin-6 protects anterior horn neurons from lethal virus-induced injury.

Authors:  Kevin D Pavelko; Charles L Howe; Kristen M Drescher; Jeff D Gamez; Aaron J Johnson; Tao Wei; Richard M Ransohoff; Moses Rodriguez
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

Review 7.  Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration.

Authors:  Suzan Dziennis; Nabil J Alkayed
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

8.  Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma.

Authors:  Rachel A Egler; Susan M Burlingame; Jed G Nuchtern; Heidi V Russell
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

9.  Erratum: The two sides of cytokine signaling and glaucomatous optic neuropathy.

Authors:  Ping Huang; Samuel Shao-Min Zhang; Chun Zhang
Journal:  J Ocul Biol Dis Infor       Date:  2009-09-09

10.  The two sides of cytokine signaling and glaucomatous optic neuropathy.

Authors:  Ping Huang; Samuel Shao-Min Zhang; Chun Zhang
Journal:  J Ocul Biol Dis Infor       Date:  2009-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.